News

Indoco Remedies Consolidated March 2025 Net Sales at Rs 390.21 crore, down 13.22% Y-o-Y
Other Operating Income: 6.32----Total Income From Operations: 390.21: 410.55: 449.64: EXPENDITURE ...
IndiaInfoline3d
Indoco Remedies Posts ₹40.4 Crore Net Loss in Q4 FY25
Indoco Remedies board of directors has proposed a final dividend of ₹0.20 per equity share of face value of ₹2 each ...
Capital Market on MSN6d
Indoco Remedies gains after receiving USFDA nod for Allopurinol drug
Allopurinol is used to prevent or lower high uric acid levels in the blood. It is also used to prevent or lower excess uric ...
Medical Dialogues6d
Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood
Mumbai: Indoco Remedies Ltd. has announced the final approval of Allopurinol Tablets USP 200 mg through its Abbreviated New ...
Pharmabiz6d
Indoco Remedies receives US FDA final approval to market allopurinol tablets USP 200 mg
Indoco Remedies receives US FDA final approval to market allopurinol tablets USP 200 mg: Our Bureau, Mumbai Friday, May 23, 2025, 12:30 Hrs [IST] Indoco Remedies Ltd., a fully int ...
What drove Indoco Remedies share price 6% higher today? Top details inside
Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets ...